What News Was in My In-Box, October 26, 2022
Quite a few varying articles in healthcare and other topics this week. Pfizer is hoping to make a killing on it mRNA vaccine, shots are approved for 6 months to five-years of age, Medicare Advantage plans, and Novartis is back again with a cancer drug. A COA has blocked student loan relief, lots of talk […]